share_log

藥明康德：2024年第一次臨時股東大會、2024年第一次A股類別股東大會和2024年第一次H股類別股東大會投票結果

WUXI APPTEC: POLL RESULTS OF THE FIRST EXTRAORDINARY GENERAL MEETING IN 2024, THE FIRST A SHARE CLASS MEETING IN 2024 AND THE FIRST H SHARE CLASS MEETING IN 2024

香港交易所 ·  Jan 5 06:28
Summary by Moomoo AI
药明康德於2024年1月5日成功召開2024年第一次臨時股東大會、A股類別股東大會及H股類別股東大會。會議在上海外高橋喜來登酒店以現場及網絡投票形式進行，並通過了關於向受託人直接回購2023年H股獎勵信託計劃所涉H股股份並予以註銷的特別決議案。臨時股東大會有約50.5007%的股份出席投票，A股類別股東大會有約48.6809%的A股股份出席投票，而H股類別股東大會則有約61.9983%的H股股份出席投票。全體董事均出席了會議，並無股東放棄表決權或表示反對。德勤華永會計師事務所擔任監票人，而方達律師事務所則見證會議並確認程序合法有效。
药明康德於2024年1月5日成功召開2024年第一次臨時股東大會、A股類別股東大會及H股類別股東大會。會議在上海外高橋喜來登酒店以現場及網絡投票形式進行，並通過了關於向受託人直接回購2023年H股獎勵信託計劃所涉H股股份並予以註銷的特別決議案。臨時股東大會有約50.5007%的股份出席投票，A股類別股東大會有約48.6809%的A股股份出席投票，而H股類別股東大會則有約61.9983%的H股股份出席投票。全體董事均出席了會議，並無股東放棄表決權或表示反對。德勤華永會計師事務所擔任監票人，而方達律師事務所則見證會議並確認程序合法有效。
MINGKAND PHARMACEUTICALS SUCCESSFULLY HELD THE FIRST EXTRAORDINARY GENERAL MEETING OF 2024, CLASS A GENERAL MEETING AND CLASS H GENERAL MEETING ON JANUARY 5, 2024. The meeting took place in the form of live and online voting at Sheraton Takahashi Hotel Shanghai and adopted a special resolution on the direct repurchase and withdrawal of H Shares under the 2023 H-Share Reward Trust Scheme from the Trustees. Approximately 50.5007% of shares were present at the Provisional General Meeting, approximately 48.6809% of Class A shares were present at the Class A General Meeting and approximately 61.9983% of H Shares were present at the Class H General Meeting. All directors attended the meeting and no shareholders gave up voting rights or expressing objections. Delkin Huayong Accounting Firm acted as a supervisor and Fangda Law Firm witnessed the meeting and confirmed the legal validity of the procedure.
MINGKAND PHARMACEUTICALS SUCCESSFULLY HELD THE FIRST EXTRAORDINARY GENERAL MEETING OF 2024, CLASS A GENERAL MEETING AND CLASS H GENERAL MEETING ON JANUARY 5, 2024. The meeting took place in the form of live and online voting at Sheraton Takahashi Hotel Shanghai and adopted a special resolution on the direct repurchase and withdrawal of H Shares under the 2023 H-Share Reward Trust Scheme from the Trustees. Approximately 50.5007% of shares were present at the Provisional General Meeting, approximately 48.6809% of Class A shares were present at the Class A General Meeting and approximately 61.9983% of H Shares were present at the Class H General Meeting. All directors attended the meeting and no shareholders gave up voting rights or expressing objections. Delkin Huayong Accounting Firm acted as a supervisor and Fangda Law Firm witnessed the meeting and confirmed the legal validity of the procedure.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more